Steven Cohen's RYTM Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 429,420 shares of Rhythm Pharmaceuticals, Inc. (RYTM) worth $45.97 M, representing 0.05% of the portfolio. First purchased in 2017-Q4, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in RYTM, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 429,420 shares. Largest reduction occurred in Q2 2018, reducing 180,000 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Rhythm Pharmaceuticals (RYTM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Rhythm Pharmaceuticals (RYTM) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +429,420 | New Buy | 429,420 | $107.04 |
| Q3 2025 | -170,832 | Sold Out | 0 | $0.00 |
| Q2 2025 | +106,990 | Add 167.59% | 170,832 | $63.19 |
| Q1 2025 | +63,842 | New Buy | 63,842 | $52.97 |
| Q4 2023 | -4,146 | Sold Out | 0 | $0.00 |
| Q3 2023 | +4,146 | New Buy | 4,146 | $22.92 |
| Q2 2023 | -11,955 | Sold Out | 0 | $0.00 |
| Q1 2023 | +11,955 | New Buy | 11,955 | $17.84 |
| Q2 2018 | -180,000 | Sold Out | 0 | $0.00 |
| Q1 2018 | +100,000 | Add 125.00% | 180,000 | $19.90 |
| Q4 2017 | +80,000 | New Buy | 80,000 | $29.06 |
Steven Cohen's Rhythm Pharmaceuticals Investment FAQs
Steven Cohen first purchased Rhythm Pharmaceuticals, Inc. (RYTM) in Q4 2017, acquiring 80,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Rhythm Pharmaceuticals, Inc. (RYTM) for 11 quarters since Q4 2017.
Steven Cohen's largest addition to Rhythm Pharmaceuticals, Inc. (RYTM) was in Q4 2025, adding 429,420 shares worth $45.97 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 429,420 shares of Rhythm Pharmaceuticals, Inc. (RYTM), valued at approximately $45.97 M.
As of the Q4 2025 filing, Rhythm Pharmaceuticals, Inc. (RYTM) represents approximately 0.05% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Rhythm Pharmaceuticals, Inc. (RYTM) was 429,420 shares, as reported at the end of Q4 2025.